Accession Number: | 0001104659-21-054611 |
Date: | 2021-04-20 |
Issuer: | BLACK DIAMOND THERAPEUTICS, INC. (BDTX) |
Original Submission Date: |
MENZEL GARRY E
C/O BLACK DIAMOND THERAPEUTICS, INC.
ONE MAIN STREET, 10TH FLOOR
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 24.33 | 2021-04-20 | deemed execution date | A | 14,921 (a) | 2031-04-19 | common stock 14,921 | $24.33 | 14,921 | direct |
ID | footnote |
---|---|
f1 | this option shall vest and become exercisable in full upon the earlier to occur of (i) june 12, 2021 and (ii) the next annual meeting of the issuer's stockholders. |